1 April 2025 false No description of principal activity Taxfiler 2024.6 10956181business:PrivateLimitedCompanyLtd2025-04-012026-03-31 109561812025-03-31 109561812025-04-012026-03-31 10956181business:AuditExemptWithAccountantsReport2025-04-012026-03-31 10956181business:FilletedAccounts2025-04-012026-03-31 109561812026-03-31 10956181business:Director12025-04-012026-03-31 10956181business:RegisteredOffice2025-04-012026-03-31 109561812025-03-31 10956181core:WithinOneYear2026-03-31 10956181core:WithinOneYear2025-03-31 10956181core:AfterOneYear2026-03-31 10956181core:AfterOneYear2025-03-31 10956181core:ShareCapitalcore:PreviouslyStatedAmount2026-03-31 10956181core:ShareCapitalcore:PreviouslyStatedAmount2025-03-31 10956181core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2026-03-31 10956181core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2025-03-31 10956181core:PreviouslyStatedAmount2026-03-31 10956181core:PreviouslyStatedAmount2025-03-31 10956181business:SmallEntities2025-04-012026-03-31 10956181countries:EnglandWales2025-04-012026-03-31 10956181core:PlantMachinery2025-04-012026-03-31 10956181core:MotorVehicles2025-03-31 10956181core:MotorVehicles2025-04-012026-03-31 10956181core:MotorVehicles2026-03-31 10956181business:OrdinaryShareClass12025-04-012026-03-31 10956181business:OrdinaryShareClass12024-04-012025-03-31 109561812024-04-012025-03-31 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 10956181 (England and Wales)
Lay Pharm Limited Unaudited accounts for the year ended 31 March 2026
Lay Pharm Limited Unaudited accounts Contents
Page
- 2 -
Lay Pharm Limited Company Information for the year ended 31 March 2026
Director
Anthony Olayiwola
Company Number
10956181 (England and Wales)
Registered Office
78 Temple Avenue Dagenham Essex RM8 1LS England
Accountants
TDC Accountancy Ltd T-As Davies & Co. Unit 18 Little Malgraves Industrial Estate Lower Dunton Road Upminster Essex RM14 3TE
- 3 -
Lay Pharm Limited Statement of financial position as at 31 March 2026
2026 
2025 
Notes
£ 
£ 
Fixed assets
Tangible assets
24,000 
- 
Current assets
Debtors
- 
9,000 
Cash at bank and in hand
6,153 
522 
6,153 
9,522 
Creditors: amounts falling due within one year
(6,639)
(6,139)
Net current (liabilities)/assets
(486)
3,383 
Total assets less current liabilities
23,514 
3,383 
Creditors: amounts falling due after more than one year
(20,000)
- 
Net assets
3,514 
3,383 
Capital and reserves
Called up share capital
100 
100 
Profit and loss account
3,414 
3,283 
Shareholders' funds
3,514 
3,383 
For the year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 8 September 2026 and were signed on its behalf by
Anthony Olayiwola Director Company Registration No. 10956181
- 4 -
Lay Pharm Limited Notes to the Accounts for the year ended 31 March 2026
1
Statutory information
Lay Pharm Limited is a private company, limited by shares, registered in England and Wales, registration number 10956181. The registered office is 78 Temple Avenue, Dagenham, Essex, RM8 1LS, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
20% S/L
4
Tangible fixed assets
Motor vehicles 
£ 
Cost or valuation
At cost 
At 1 April 2025
- 
Additions
30,000 
At 31 March 2026
30,000 
Depreciation
Charge for the year
6,000 
At 31 March 2026
6,000 
Net book value
At 31 March 2026
24,000 
- 5 -
Lay Pharm Limited Notes to the Accounts for the year ended 31 March 2026
5
Debtors
2026 
2025 
£ 
£ 
Amounts falling due within one year
Other debtors
- 
9,000 
6
Creditors: amounts falling due within one year
2026 
2025 
£ 
£ 
Taxes and social security
5,257 
4,752 
Loans from directors
382 
427 
Accruals
1,000 
960 
6,639 
6,139 
7
Creditors: amounts falling due after more than one year
2026 
2025 
£ 
£ 
Obligations under finance leases and hire purchase contracts
20,000 
- 
8
Share capital
2026 
2025 
£ 
£ 
Allotted, called up and fully paid:
100 Ordinary shares of £1 each
100 
100 
9
Average number of employees
During the year the average number of employees was 1 (2025: 1).
- 6 -